Ventilator News and Research

RSS

ECMO: A last-resort therapy for extremely severe cases of influenza

Physicians at the University of Alabama at Birmingham are employing a technology known as ECMO as a last-resort therapy for extremely severe cases of influenza. ECMO, short for extracorporeal membrane oxygenation, is a sort of portable heart/lung bypass machine.

23 Jan 2014

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

The First Amendment protects the speech of short, elderly women and large and intimidating men equally, but you would be forgiven for thinking otherwise after oral arguments before the Supreme Court Wednesday morning.

17 Jan 2014

First Edition: January 15, 2014

Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.

15 Jan 2014

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the Company's New Drug Application for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections.

30 Dec 2013

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

UHC announced its selection as a coordinating entity for a 3-year, $7.3 million contract from the Agency for Healthcare Research and Quality that has been awarded to the Johns Hopkins Armstrong Institute for Patient Safety and Quality to reduce ventilator-associated pneumonia in hospitals.

10 Dec 2013

Nurse-led initiatives in Indiana improve patient outcomes

Nurse-led initiatives in Indiana measurably improved patient outcomes while demonstrating anticipated financial savings of more than $5.2 million to their organizations, according to initial results from a hospital-based nurse leadership and innovation training program launched last year by the American Association of Critical-Care Nurses.

6 Dec 2013

Quadriplegics have heightened risk of central sleep apnea

There are over a million people with spinal cord injuries in the United States alone with an estimated 11,000 new cases every year. Furthermore, it is estimated that there are, at least, 100,000 veterans with SCI, making the VA the largest integrated health care system in the world for SCI care. But despite this large prevalence, researchers are still discovering all the various ways that SCI affect those with this condition beyond the obvious paralysis.

6 Dec 2013

Researcher studies CPOT for accurate measurement of patient's pain level post cardiac surgery

How do you measure the pain of a patient who can't communicate? A Rhode Island Hospital researcher studied an observational pain scale in cardiac surgery patients, and found that the Critical-Care Pain Observation Tool (CPOT) provided an accurate measure of a patient's pain level.

6 Dec 2013

University of Wisconsin Hospital and Clinics recognized with 2013 Partnership in Prevention Award

The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the University of Wisconsin Hospital and Clinics (UWHC) with the 2013 Partnership in Prevention Award for achieving sustainable improvements towards eliminating healthcare-associated infections (HAIs).

27 Nov 2013

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Therapeutic hypothermia - cooling the body and brain down to 33-C - is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects. However, keeping the temperature steady at 36-C is just as effective, a study led by Lund University researchers has found.

20 Nov 2013

Healthcare-associated infections are less likely to occur in favorable critical care work environments

Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).

4 Nov 2013

Identifying gaps in infection prevention practices may help improve patient safety, shows study

Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

30 Oct 2013

Diaphragm pacing systems improve quality of life for ALS patients

Respiratory failure is one of the major complications associated with amyotrophic lateral sclerosis. The quest for alternative approaches for treating respiratory failure has led to the study, and subsequent FDA approval, of diaphragm pacing for use in ALS patients. However, there are still important unanswered questions about its benefit and impact.

18 Oct 2013

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that it has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate its AEROSURF phase 2 clinical program.

17 Oct 2013

Study: Statin do not improve VAP outcomes

Laurent Papazian, M.D., Ph.D., of H-pital Nord, Marseille, France, and colleagues conducted a study to determine whether statin therapy decreased day-28 mortality among intensive care unit patients with ventilator-associated pneumonia.

11 Oct 2013

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.

5 Oct 2013

Johns Hopkins receives $7.3M contract to reduce ventilator-associated pneumonia

The Johns Hopkins Armstrong Institute for Patient Safety and Quality has been awarded a three-year, $7.3 million contract from the Agency for Healthcare Research & Quality to bring its proven checklist for reducing ventilator-associated pneumonia — the most lethal of all hospital-acquired infections — to hospitals nationwide.

25 Sep 2013

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $10,000 to $50,000.

13 Sep 2013

Research roundup: The financial burden of hospital acquired infections

Health care–associated infections (HAIs) account for a large proportion of the harms caused by health care and are associated with high costs. ... [Using a simulation, the researchers found that the] total annual costs for the 5 major infections were $9.8 billion (95% CI, $8.3-$11.5 billion), with surgical site infections contributing the most to overall costs (33.7% of the total), followed by ventilator-associated pneumonia (31.6%), central line–associated bloodstream infections (18.9%), C difficile infections (15.4%), and catheter-associated urinary tract infections (<1%). ... recent analyses indicate that at least 50% are preventable. ...

7 Sep 2013

Obama administration to provide veterans' same-sex spouses benefits

Attorney General Eric Holder told Congress in a letter that the recent Supreme Court decision clears the way for this change in policy.

6 Sep 2013

Ventilator News and Research

ECMO: A last-resort therapy for extremely severe cases of influenza

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

First Edition: January 15, 2014

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

CUSP project aims to reduce ventilator-associated pneumonia in hospitals

Nurse-led initiatives in Indiana improve patient outcomes

Quadriplegics have heightened risk of central sleep apnea

Researcher studies CPOT for accurate measurement of patient's pain level post cardiac surgery

University of Wisconsin Hospital and Clinics recognized with 2013 Partnership in Prevention Award

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Healthcare-associated infections are less likely to occur in favorable critical care work environments

Identifying gaps in infection prevention practices may help improve patient safety, shows study

Diaphragm pacing systems improve quality of life for ALS patients

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Study: Statin do not improve VAP outcomes

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Johns Hopkins receives $7.3M contract to reduce ventilator-associated pneumonia

AACN to grant nearly $200,000 to support acuity and critical care nursing practice

Research roundup: The financial burden of hospital acquired infections

Obama administration to provide veterans' same-sex spouses benefits

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News